Predictors of Post-Bariatric Surgery Hypoglycemia: A Multicenter Retrospective Cohort Study
Mansour Bahardoust1, Ali Ranjbarpazuki2, Mohammadsadra Shamohammadi3
1Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Introduction:
Post-bariatric hypoglycemia (PBH) is a recognized complication that typically occurs within 1-3 years after bariatric surgery. We aimed to identify predictors of PBH in a large multicenter cohort.
Materials And Methods:
This retrospective, multicenter cohort study reviewed the medical records of 952 obese patients (body mass index (BMI) ≥ 35 kg/m2) who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2020 and 2024 at three medical centers. PBH in a patient after bariatric surgery was defined as biochemically confirmed hypoglycemia less than 3.0 mmol/L (54 mg/dL) with typical symptoms of hypoglycemia, according to Whipple's triad. PBH incidence was evaluated at 12, 15, and 18 months postoperatively. Multivariable logistic regression was used to estimate adjusted associations with PBH after 12 months.
Results:
Cumulative PBH incidence was 25.9% at 12 months, 29.3% at 15 months, and 35.4% at 18 months. Factors associated with increased PBH risk included female sex (Odds Ratio (OR): 1.91, 95% Confidence Interval: 1.11-2.71), high school graduate (OR: 1.61, 95% CI: 1.10-2.11), vitamin B1/B12 deficiency (OR: 1.45, 95% CI: 1.04-1.85), and RYGB surgery (OR: 1.81, 95% CI: 1.11-2.51). Protective factors included having type 2 diabetes (OR: 0.75, 95% CI: 0.55-0.96), higher baseline HbA1c (OR: 0.97, 95% CI: 0.95-0.99), and longer diabetes duration (OR: 0.95, 95% CI: 0.91-0.99).
Conclusion:
PBH is a challenging complication after bariatric surgery. Our findings underscore the importance of considering metabolic, sociodemographic, and nutritional factors in assessing the risk of PBH.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...


